⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2112375 | 0.75 | — | — | |
| SCHEMBL8796120 | 0.75 | — | — | |
| SCHEMBL17628498 | 0.75 | — | — | |
| SCHEMBL9001234 | 0.74 | GAA (0.39) | — | |
| SCHEMBL22445221 | 0.65 | — | — | |
| SCHEMBL4963706 | 0.65 | — | — | |
| SCHEMBL1222916 | 0.64 | HSD11B1 (0.34) | — | |
| SCHEMBL155348 | 0.64 | — | — | |
| SCHEMBL706933 | 0.63 | HSD11B1 (0.38) | — | |
| SCHEMBL17586267 | 0.61 | PKM (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002002190-A2 | PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES BY GLUTATHIONE AND PHASE II DETOXIFICATION ENZYMES | JOHNS HOPKINS SCHOOL OF MEDICINE (US) | 2002-01-10 | — | — | WO | claimed |
| WO-2002002190-A2 | PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES BY GLUTATHIONE AND PHASE II DETOXIFICATION ENZYMES | JOHNS HOPKINS SCHOOL OF MEDICINE (US) | 2002-01-10 | — | — | WO | disclosed |